Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study.

MLA

Lewin, Andrew J., et al. “Triple-Combination Treatment with Olmesartan Medoxomil/Amlodipine/ Hydrochlorothiazide in Hispanic/Latino Patients with Hypertension: The TRINITY Study.” Ethnicity & Disease, vol. 24, no. 1, Winter 2014, pp. 41–47. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=24620447&authtype=sso&custid=ns315887.

APA

Lewin, A. J., Kereiakes, D. J., Chrysant, S. G., Izzo, J. L., Jr, Oparil, S., Lee, J., Fernandez, V., & Melino, M. (2014). Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study. Ethnicity & Disease, 24(1), 41–47.

Chicago

Lewin, Andrew J, Dean J Kereiakes, Steven G Chrysant, Joseph L Izzo Jr, Suzanne Oparil, James Lee, Victor Fernandez, and Michael Melino. 2014. “Triple-Combination Treatment with Olmesartan Medoxomil/Amlodipine/ Hydrochlorothiazide in Hispanic/Latino Patients with Hypertension: The TRINITY Study.” Ethnicity & Disease 24 (1): 41–47. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=24620447&authtype=sso&custid=ns315887.